Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.

Ruffieux, Yann; Lemsalu, Liis; Aebi-Popp, Karoline; Calmy, Alexandra; Cavassini, Matthias; Fux, Christoph A; Günthard, Huldrych F; Marzolini, Catia; Scherrer, Alexandra; Vernazza, Pietro; Keiser, Olivia; Egger, Matthias (2019). Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. Journal of the International AIDS Society, 22(8), e25339. BioMed Central 10.1002/jia2.25339

[img]
Preview
Text
Ruffieux JIntAIDSSoc 2019.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (227kB) | Preview

INTRODUCTION In many countries, mortality due to suicide is higher among people living with HIV than in the general population. We aimed to analyse trends in suicide mortality before and after the introduction of triple combination antiretroviral therapy (cART), and to identify risk factors associated with death from suicide in Switzerland. METHODS We analysed data from the Swiss HIV Cohort Study from the pre-cART (1988-1995), earlier cART (1996-2008) and later cART (2009-2017) eras. We used multivariable Cox regression to assess risk factors for death due to suicide in the ART era and computed standardized mortality ratios (SMRs) to compare mortality rates due to suicide among persons living with HIV with the general population living in Switzerland, using data from the Swiss National Cohort. RESULTS AND DISCUSSION We included 20,136 persons living with HIV, of whom 204 (1.0%) died by suicide. In men, SMRs for suicide declined from 12.9 (95% CI 10.4-16.0) in the pre-cART era to 2.4 (95% CI 1.2-5.1) in the earlier cART and 3.1 (95% CI 2.3-4.3) in the later cART era. In women, the corresponding ratios declined from 14.2 (95% CI 7.9-25.7) to 10.2 (3.8-27.1) and to 3.3 (95% CI 1.5-7.4). Factors associated with death due to suicide included gender (adjusted hazard ratio 0.58 (95% CI 0.38-0.87) comparing women with men), nationality (1.95 (95% CI 1.34-2.83) comparing Swiss with other), Centers for Disease Control and Prevention clinical stage (0.33 (95% CI 0.24-0.46) comparing stage A with C), transmission group (2.64 (95% CI 1.71-4.09) for injection drug use and 2.10 (95% CI 1.36-3.24) for sex between men compared to other), and mental health (2.32 (95% CI 1.71-3.14) for a history of psychiatric treatment vs. no history). There was no association with age. CONCLUSIONS Suicide rates have decreased substantially among people living with HIV in the last three decades but have remained about three times higher than in the general population since the introduction of cART. Continued emphasis on suicide prevention among men and women living with HIV is important.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Ruffieux, Yann; Aebi-Popp, Karoline and Egger, Matthias

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1758-2652

Publisher:

BioMed Central

Funders:

[4] Swiss National Science Foundation

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

27 Aug 2019 12:45

Last Modified:

22 Oct 2019 19:21

Publisher DOI:

10.1002/jia2.25339

PubMed ID:

31423727

Uncontrolled Keywords:

HIV SMR Switzerland comparative study intravenous drug use suicide

BORIS DOI:

10.7892/boris.132790

URI:

https://boris.unibe.ch/id/eprint/132790

Actions (login required)

Edit item Edit item
Provide Feedback